181 related articles for article (PubMed ID: 26989091)
1. Lung inflammation stalls Th17-cell migration en route to the central nervous system during the development of experimental autoimmune encephalomyelitis.
Kanayama M; Danzaki K; He YW; Shinohara ML
Int Immunol; 2016 Sep; 28(9):463-9. PubMed ID: 26989091
[TBL] [Abstract][Full Text] [Related]
2. Frontline Science: Induction of experimental autoimmune encephalomyelitis mobilizes Th17-promoting myeloid derived suppressor cells to the lung.
Glenn JD; Liu C; Whartenby KA
J Leukoc Biol; 2019 May; 105(5):829-841. PubMed ID: 30762897
[TBL] [Abstract][Full Text] [Related]
3. Blockade of CD47 ameliorates autoimmune inflammation in CNS by suppressing IL-1-triggered infiltration of pathogenic Th17 cells.
Gao Q; Zhang Y; Han C; Hu X; Zhang H; Xu X; Tian J; Liu Y; Ding Y; Liu J; Wang C; Guo Z; Yang Y; Cao X
J Autoimmun; 2016 May; 69():74-85. PubMed ID: 26994903
[TBL] [Abstract][Full Text] [Related]
4. Remote control of T
Vijitha N; Engel DR
J Leukoc Biol; 2019 May; 105(5):827-828. PubMed ID: 30958568
[TBL] [Abstract][Full Text] [Related]
5. SIRPα on CD11c
Nishimura T; Saito Y; Washio K; Komori S; Respatika D; Kotani T; Murata Y; Ohnishi H; Mizobuchi S; Matozaki T
Eur J Immunol; 2020 Oct; 50(10):1560-1570. PubMed ID: 32438469
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
[TBL] [Abstract][Full Text] [Related]
7. IL-9 promotes Th17 cell migration into the central nervous system via CC chemokine ligand-20 produced by astrocytes.
Zhou Y; Sonobe Y; Akahori T; Jin S; Kawanokuchi J; Noda M; Iwakura Y; Mizuno T; Suzumura A
J Immunol; 2011 Apr; 186(7):4415-21. PubMed ID: 21346235
[TBL] [Abstract][Full Text] [Related]
8. Sialomucin CD43 regulates T helper type 17 cell intercellular adhesion molecule 1 dependent adhesion, apical migration and transendothelial migration.
Velázquez FE; Anastasiou M; Carrillo-Salinas FJ; Ngwenyama N; Salvador AM; Nevers T; Alcaide P
Immunology; 2019 May; 157(1):52-69. PubMed ID: 30690734
[TBL] [Abstract][Full Text] [Related]
9. IFN-β inhibits T cells accumulation in the central nervous system by reducing the expression and activity of chemokines in experimental autoimmune encephalomyelitis.
Cheng W; Zhao Q; Xi Y; Li C; Xu Y; Wang L; Niu X; Wang Z; Chen G
Mol Immunol; 2015 Mar; 64(1):152-62. PubMed ID: 25433436
[TBL] [Abstract][Full Text] [Related]
10. CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.
Chung CY; Liao F
J Neuroinflammation; 2016 Apr; 13(1):76. PubMed ID: 27068264
[TBL] [Abstract][Full Text] [Related]
11. Contribution of LTi and T
Schropp V; Rohde J; Rovituso DM; Jabari S; Bharti R; Kuerten S
J Neuroinflammation; 2019 May; 16(1):111. PubMed ID: 31138214
[TBL] [Abstract][Full Text] [Related]
12. Interferon-γ orchestrates the number and function of Th17 cells in experimental autoimmune encephalomyelitis.
Berghmans N; Nuyts A; Uyttenhove C; Van Snick J; Opdenakker G; Heremans H
J Interferon Cytokine Res; 2011 Jul; 31(7):575-87. PubMed ID: 21348780
[TBL] [Abstract][Full Text] [Related]
13. T-cell-specific deletion of STIM1 and STIM2 protects mice from EAE by impairing the effector functions of Th1 and Th17 cells.
Ma J; McCarl CA; Khalil S; Lüthy K; Feske S
Eur J Immunol; 2010 Nov; 40(11):3028-42. PubMed ID: 21061435
[TBL] [Abstract][Full Text] [Related]
14. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis.
Jadidi-Niaragh F; Mirshafiey A
Scand J Immunol; 2011 Jul; 74(1):1-13. PubMed ID: 21338381
[TBL] [Abstract][Full Text] [Related]
15. IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: Current and future developments.
Luchtman DW; Ellwardt E; Larochelle C; Zipp F
Cytokine Growth Factor Rev; 2014 Aug; 25(4):403-13. PubMed ID: 25153998
[TBL] [Abstract][Full Text] [Related]
16. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA223 promotes pathogenic T-cell development and autoimmune inflammation in central nervous system in mice.
Satoorian T; Li B; Tang X; Xiao J; Xing W; Shi W; Lau KH; Baylink DJ; Qin X
Immunology; 2016 Aug; 148(4):326-38. PubMed ID: 27083389
[TBL] [Abstract][Full Text] [Related]
18. The ribosomal S6 kinase inhibitor BI-D1870 ameliorated experimental autoimmune encephalomyelitis in mice.
Takada I; Yogiashi Y; Makishima M
Immunobiology; 2016 Feb; 221(2):188-92. PubMed ID: 26386981
[TBL] [Abstract][Full Text] [Related]
19. B7-H1 Selectively Controls TH17 Differentiation and Central Nervous System Autoimmunity via a Novel Non-PD-1-Mediated Pathway.
Herold M; Posevitz V; Chudyka D; Hucke S; Groß C; Kurth F; Leder C; Loser K; Kurts C; Knolle P; Klotz L; Wiendl H
J Immunol; 2015 Oct; 195(8):3584-95. PubMed ID: 26378076
[TBL] [Abstract][Full Text] [Related]
20. The critical role of antigen-presentation-induced cytokine crosstalk in the central nervous system in multiple sclerosis and experimental autoimmune encephalomyelitis.
Sosa RA; Forsthuber TG
J Interferon Cytokine Res; 2011 Oct; 31(10):753-68. PubMed ID: 21919736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
